Therapeutic Drug Monitoring-Guided Adjuvant Tamoxifen Dosing in Patients with Early Breast Cancer: A Cost-Effectiveness Analysis from the Prospective TOTAM Trial

C.L. Braal*, A. Kleijburg, A. Jager, S.L.W. Koolen, R.H.J. Mathijssen, I.C. Ramos, P. Wetzelaer, C.A. Uyl-de Groot

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)163-175
Number of pages13
JournalClinical Drug Investigation
Volume42
Issue number2
Early online date12 Jan 2022
DOIs
Publication statusPublished - Feb 2022

Keywords

  • DOSE-ESCALATION
  • CYP2D6 GENOTYPE
  • LIFE

Cite this